Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children

Pediatric Nephrology

Volumn 21, Issue 5, 2006, Pages 655-662

  Lau, Keith K ^a,c   Jones, Deborah P ^a,c   Hastings, Margaret C ^a,c   Gaber, Lillian W ^b   Ault, Bettina H ^a,c  

^a LE BONHEUR CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

African American; Children; Severe lupus nephritis; Short term outcome

Indexed keywords

ALBUMIN; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; AFRICAN AMERICAN; ALBUMIN BLOOD LEVEL; ARTICLE; CAUCASIAN; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE SEVERITY; DRUG DOSE REGIMEN; ETHNOLOGY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; TREATMENT OUTCOME; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AFRICAN AMERICANS; AZATHIOPRINE; BIOPSY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS NEPHRITIS; MALE; MYCOPHENOLIC ACID; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646156190     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0060-3     Document Type: Article

References (34)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E (1993) Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72:113-124
2. Meislin AG, Rothfield N (1968) Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42:37-49
3. Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34:866-872
4. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, Garcia-Carrasco M, Seisdedos L, Ingelmo M (1998) Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456-459
5. Pollak VE, Pirani CL, Schwartz FD (1997) The natural history of the renal manifestations of systemic lupus erythematosus. 1964. J Am Soc Nephrol 8:1189-1198
6. Bakkaloglu A (2001) Lupus nephropathy in children. Nephrol Dial Transplant 16 [Suppl 6]:126-128
7. Lee BW, Yap HK, Yip WC, Low PS, Saw AH, Tay JS, Wong HB (1987) A 10 year review of systemic lupus erythematosus in Singapore children. Aust Paediatr J 23:163-165
8. Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M (1991) Predictors of one year outcome in lupus nephritis: The importance of renal biopsy. Q J Med 81:907-918
9. McCurdy DK, Lehman TJ, Berstein B, Hanson V, King KK, Nadorra R, Landing B (1992) Lupus nephritis: Prognostic factors in children. Pediatrics 89:240-246
10. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A (1996) Lupus nephritis in children: A longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924-929
11. Sumboonnanonda A, Vongjirad A, Suntornpoch V, Laohapand T, Parichatikanond P (1998) Renal pathology and long-term outcome in childhood SLE. J Med Assoc Thai 81:830-834
12. Emre S, Bilge I, Sirin A, Kilicaslan I, Nayir A, Oktem F, Uysal V (2001) Lupus nephritis in children: Prognostic significance of clinicopathological findings. Nephron 87:118-126
13. Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, Perfumo F (2002) Childhood-onset lupus nephritis: A single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol 15:123-129
14. Hagelberg S, Lee Y, Bargman J, Mah G, R, Schneider Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Long-term follow up of childhood lupus nephritis. J Rheumatol 29:2635-2642
15. Vyas S, Hidalgo G, Baqi N, Von Gizyki H, Singh A (2002) Outcome in African-American children of neuropsychiatric lupus and lupus nephritis. Pediatr Nephrol 17:45-49
16. Al Salloum AA (2003) Cyclophosphamide therapy for lupus nephritis: Poor renal survival in Arab children. Pediatr Nephrol 18:357-361
17. Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, Ognjanovic M, Minic A, Stajic N (2004) Lupus nephritis in childhood: A review of 53 patients followed at a single center. Pediatr Nephrol 19:36-44
18. Wang LC, Yang YH, Lu MY, Chiang BL (2004) Retrospective analysis of the renal outcome of pediatric lupus nephritis. Clin Rheumatol 23:318-323
19. Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children - A review of 167 patients. Pediatrics 94:335-340
20. Austin HA, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int 45:544-550
21. Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J, Radhakrishnan J (2003) Prognosis in proliferative lupus nephritis: The role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 18:2039-2046
22. Tejani A, Nicastri AD, Chen CK, Fikrig S, Gurumurthy K (1983) Lupus nephritis in black and Hispanic children. Am J Dis Child 137:481-483
23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
24. Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE (1992) Controlled trial of pulse methylprednisone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 26:741-745
25. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 25:689-95
26. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. (1996) Update on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-658
27. Schwartz GL, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
28. Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158-166
29. Bansal VK, Beto JA (1997) Treatment of lupus nephritis: A meta-analysis of clinical trials. Am J Kidney Dis 29:193-199
30. Cole BR, Brocklebank JT, Kienstra RA, Kissane JM, Robson AM (1976) "Pulse" methylprednisone therapy in the treatment of severe glomerulonephritis. J Pediatr 88:307-314
31. Cameron JS (1994) Lupus nephritis in childhood and adolescence. Pediatr Nephrol 8:230-234
32. Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschenes G, Kone-Paut I, Leblanc T, Loirat C, Niaudet P, Piette JC, Prieur AM, Quartier P, Bouissou F, Foulard M, Leverger G, Lemelle I, Pilet P, Rodiere M, Sirvent N, Cochat B (2005) Initial presentation of childhood-onset systemic lupus erythematosis: A French multicenter study. J Pediatr 146:648-653
33. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE (1995) High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 10:1620-1628
34. Chan TM, Tse KC, Tang CS, Mok MY, Li FK; Hong Kong Nephrology Study Group (2005) Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16:1076-1084